Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/18/2008WO2008152388A1 Silicon-containing compounds for treatment or prevention of bone loss or restoration of bone mass, or augmentation of bone mass
12/18/2008WO2008152387A1 Quinazoline derivatives as pi3 kinase inhibitors
12/18/2008WO2008152366A1 Improvements in and relating to mammalian reproduction
12/18/2008WO2008152347A2 Pack of medicinal tablets
12/18/2008WO2008152334A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008WO2008152333A2 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/18/2008WO2008152332A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008WO2008152331A1 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008WO2008152330A2 Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders
12/18/2008WO2008152260A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
12/18/2008WO2008152226A2 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof
12/18/2008WO2008152207A1 Nutritional compositions
12/18/2008WO2008152178A1 Cysteine proteases inhibitors
12/18/2008WO2008152173A1 Phenolic extracts of almond peel containing procyanidins, propelargonidins and prodelphinidins, and method for preparation thereof
12/18/2008WO2008152159A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
12/18/2008WO2008152149A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008WO2008152142A1 2 -aminoquinazoline derivatives and their therapeutic uses
12/18/2008WO2008152131A2 Rnai inhibition of alpha-enac expression
12/18/2008WO2008152127A1 Terpenes with antifungal activity against malassezia yeasts
12/18/2008WO2008152106A1 Pharmaceutical formulation comprising an insulin derivative
12/18/2008WO2008152099A2 Aryl/hetarylamides as modulators of the ep2 receptor
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152093A2 Diaminopyrimidines as modulators of the ep2 receptor
12/18/2008WO2008152090A1 Novel compound
12/18/2008WO2008152089A1 Novel compounds
12/18/2008WO2008152086A2 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
12/18/2008WO2008152081A2 Anthelmintic benzo[d]isoxazolyl benzamide derivatives
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008152068A2 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
12/18/2008WO2008152067A1 An allergen dosage form comprising an antihistamine
12/18/2008WO2008152065A1 Composition and uses of a retinoid, an anti-irritant compound and benzoyl peroxide, in acne
12/18/2008WO2008152064A1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne
12/18/2008WO2008152015A1 Composition for the improvement of functional difficulties due to articular cartilage disorders
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008152013A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008WO2008151969A1 Piperazine and [1,4] diazepan derivatives as nk antagonists
12/18/2008WO2008151927A2 6-n-substituted benz imidazole derivatives as acid pump antagonists
12/18/2008WO2008151898A1 Disaccharides for the treatment of tendons, ligaments and bones
12/18/2008WO2008151833A2 Compounds for the modulation of huntingtin aggregation, methods and means for identifying such compounds
12/18/2008WO2008151811A2 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate
12/18/2008WO2008151745A1 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative
12/18/2008WO2008151734A1 Pde inhibitors for the treatment of hearing impairment
12/18/2008WO2008151702A1 Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
12/18/2008WO2008151677A1 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it
12/18/2008WO2008151639A2 Oligonucleotides for modulation of target rna activity
12/18/2008WO2008151632A1 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine for the treatment of irritable bowel syndrome (ibs)
12/18/2008WO2008151558A1 Azaindole-indole coupled derivatives, preparation methods and uses thereof
12/18/2008WO2008151519A1 USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-β1 SIGNALING PATHWAY
12/18/2008WO2008151515A1 Fibrate carboxylate compounds, preparation methods and uses thereof
12/18/2008WO2008151502A1 Enrofloxacin microcapsule formulation and preparation method thereof
12/18/2008WO2008151437A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
12/18/2008WO2008151434A1 Small cationic antimicrobial peptides
12/18/2008WO2008151433A1 Injectable polymer-lipid blend for localized drug delivery
12/18/2008WO2008151415A1 Combination for treatment of diabetes mellitus
12/18/2008WO2008151412A1 Synergistic inhibition of h1n1 and h3n2 influenza viruses by aurintricarboxylic acid with amantadine
12/18/2008WO2008151389A1 Chemically modified macromolecules
12/18/2008WO2008134513A3 Copper lowering treatment of autoimmune diseases
12/18/2008WO2008131103A3 Drug discovery methods for aurora kinase inhibitors
12/18/2008WO2008131062A3 Process for preparing capecitabine
12/18/2008WO2008131000A3 7-substituted indole mcl-1 inhibitors
12/18/2008WO2008130879A3 Tetrahydroindole and tetrahydroindazole derivatives
12/18/2008WO2008130616A3 Diaryl morpholines as cb1 modulators
12/18/2008WO2008130332B1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008129318A3 A foam material for medical use and method for producing same
12/18/2008WO2008129270A3 Compositions comprising anti-inflammatory compounds
12/18/2008WO2008128654A3 Use of fungicides for treating fish mycoses
12/18/2008WO2008127364A3 Antiviral compounds and use thereof
12/18/2008WO2008127287A9 Materials and methods for wound treatment
12/18/2008WO2008127226A3 P13 kinase antagonists
12/18/2008WO2008125846A3 Genetic suppression and replacement
12/18/2008WO2008125778A3 Rehydration composition for preparing a solute by reconstitution in water
12/18/2008WO2008124907A3 Resveratrol-containing composition for modulating bone formation
12/18/2008WO2008124192A3 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
12/18/2008WO2008121467A3 Combination therapy for treating cancer
12/18/2008WO2008120548A3 Oral disintegrating tablet
12/18/2008WO2008119146A3 Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd
12/18/2008WO2008118849A3 Hiv-1 protease inhibitors
12/18/2008WO2008118391A3 Triazinone and diazinone derivatives useful as hsp90 inhibitors
12/18/2008WO2008116215A3 Phosphorus binder for treatment of renal disease
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008115974A3 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
12/18/2008WO2008115259A3 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases
12/18/2008WO2008113992A3 Gel compositions comprising urea derivatives
12/18/2008WO2008113756A3 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/18/2008WO2008112695A3 Pyrazolo [3,4-d] pyrimidines and 1, 2, 5, 6-tetraaza- as- indacenes as protein kinase inhibitors for cancer treatment
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008109833A3 Polynucleotides and polypeptides identified by iviat screening and methods of use
12/18/2008WO2008109556B1 Nucleic acid compounds for inhibiting telomerase gene expression and uses thereof
12/18/2008WO2008109546B1 Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof
12/18/2008WO2008109506B1 Nucleic acid compounds for inhibiting jun gene expression and uses thereof
12/18/2008WO2008109494B1 Nucleic acid compounds for inhibiting stat3 gene expression and uses thereof
12/18/2008WO2008109473B1 Nucleic acid compounds for inhibiting abcb1 gene expression and uses thereof
12/18/2008WO2008109449B1 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof
12/18/2008WO2008109381B1 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof
12/18/2008WO2008109380B1 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
12/18/2008WO2008108825A3 Neuroprotective compositions and methods
12/18/2008WO2008108793A9 Prevention of nuclear, solar, and other radiation-induced tissue damage